Brown Advisory
AGIO icon

Brown Advisory’s Agios Pharmaceuticals AGIO Stock Holding History

Brown Advisory’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,395
Closed -$203K – 1243
2021
Q3 		$203K Sell
4,395
-1,025
-19% -$49.5K ﹤0.01% 1037
2021
Q2 		$298K Hold
5,420
– – ﹤0.01% 941
2021
Q1 		$280K Hold
5,420
– – ﹤0.01% 961
2020
Q4 		$234K Buy
+5,420
New +$214K ﹤0.01% 933
2020
Q3 		– Sell
-5,439
Closed -$291K – 968
2020
Q2 		$291K Sell
5,439
-340
-6% -$15.7K ﹤0.01% 821
2020
Q1 		$205K Sell
5,779
-1,125
-16% -$52K ﹤0.01% 860
2019
Q4 		$330K Sell
6,904
-359,330
-98% -$13.6M ﹤0.01% 856
2019
Q3 		$11.9M Buy
366,234
+7,007
+2% +$290K 0.03% 298
2019
Q2 		$17.9M Sell
359,227
-14,782
-4% -$790K 0.05% 255
2019
Q1 		$25.2M Buy
374,009
+26,496
+8% +$1.54M 0.07% 217
2018
Q4 		$16M Buy
347,513
+3,736
+1% +$231K 0.05% 264
2018
Q3 		$26.5M Buy
343,777
+32,799
+11% +$2.64M 0.08% 217
2018
Q2 		$26.2M Buy
310,978
+4,813
+2% +$420K 0.08% 212
2018
Q1 		$25M Buy
306,165
+1,640
+0.5% +$127K 0.08% 207
2017
Q4 		$17.4M Buy
304,525
+13,386
+5% +$842K 0.06% 246
2017
Q3 		$19.4M Buy
291,139
+22,736
+8% +$1.37M 0.06% 232
2017
Q2 		$13.8M Buy
268,403
+4,861
+2% +$249K 0.04% 268
2017
Q1 		$15.4M Buy
263,542
+142,181
+117% +$6.82M 0.05% 246
2016
Q4 		$5.06M Buy
+121,361
New +$6.37M 0.02% 373

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Brown Advisory's AGIO Position: Q4 2021 in Review

Brown Advisory sold out of Agios Pharmaceuticals (AGIO) in Q4 2021, closing a stake of 4,395 shares — an estimated $203K sold.

Brown Advisory first reported a position in AGIO in Q4 2016 and held it in 19 quarters. The position peaked at $26.5M in Q3 2018. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2021.

  • Brown Advisory reported no remaining Agios Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Brown Advisory sold 4,395 Agios Pharmaceuticals shares in Q4 2021, an estimated $203K.
  • Brown Advisory first reported a position in Agios Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Brown Advisory's Agios Pharmaceuticals position peaked at $26.5M in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2021.

Based on Brown Advisory's 13F filing for Q4 2021, filed 27 Jan 2022.